Report Detail
Global Neuromodulation Devices and Implantable Infusion Pumps Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3319077 |
- 15 April, 2019 |
- Global |
- 117 Pages |
- GIR (Global Info Research) |
- Other
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
Scope of the Report:
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
The worldwide market for Neuromodulation Devices and Implantable Infusion Pumps is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Neuromodulation Devices and Implantable Infusion Pumps in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Market Segment by Applications, can be divided into
Parkinson's disease
Epilepsy
Pain
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales, revenue and global market share of Neuromodulation Devices and Implantable Infusion Pumps in 2017 and 2018.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Spinal Cord Stimulation
- 1.2.2 Deep Brain Stimulation
- 1.2.3 Sacral Nerve Stimulation
- 1.2.4 Vagal Nerve Stimulation
- 1.2.5 Gastric Stimulation
- 1.2.6 Transcranial magnetic Stimulation
- 1.2.7 Transcutaneous Electrical Stimulation
- 1.2.8 Other
- 1.3 Market Analysis by Applications
- 1.3.1 Parkinson's disease
- 1.3.2 Epilepsy
- 1.3.3 Pain
- 1.3.4 Other
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Medtronic
- 2.1.1 Business Overview
- 2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Boston Scientific Corporation
- 2.2.1 Business Overview
- 2.2.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 St. Jude Medical
- 2.3.1 Business Overview
- 2.3.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Synapse Biomedical
- 2.4.1 Business Overview
- 2.4.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Nevro Corporation
- 2.5.1 Business Overview
- 2.5.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Neuropace
- 2.6.1 Business Overview
- 2.6.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Cyberonics
- 2.7.1 Business Overview
- 2.7.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 Autonomic Technologies
- 2.8.1 Business Overview
- 2.8.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.9 Avery Biomedical
- 2.9.1 Business Overview
- 2.9.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.10 Greatbatch Medical
- 2.10.1 Business Overview
- 2.10.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
- 2.10.2.1 Product A
- 2.10.2.2 Product B
- 2.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2018
- 3.3.2 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Regions
- 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Regions
- 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
5 North America Neuromodulation Devices and Implantable Infusion Pumps by Country
- 5.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Country
- 5.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Country (2014-2019)
- 5.2 United States Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 5.3 Canada Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 5.4 Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
6 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
- 6.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Country
- 6.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 6.3 UK Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 6.4 France Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 6.5 Russia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 6.6 Italy Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
7 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps by Country
- 7.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Country (2014-2019)
- 7.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 7.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 7.4 Korea Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 7.5 India Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
8 South America Neuromodulation Devices and Implantable Infusion Pumps by Country
- 8.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Country
- 8.1.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 8.3 Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 8.4 Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
9 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
- 9.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 9.3 Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 9.4 Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
- 9.6 South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2014-2019)
10 Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment by Type
- 10.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2014-2019)
- 10.2 Spinal Cord Stimulation Sales Growth and Price
- 10.2.1 Global Spinal Cord Stimulation Sales Growth (2014-2019)
- 10.2.2 Global Spinal Cord Stimulation Price (2014-2019)
- 10.3 Deep Brain Stimulation Sales Growth and Price
- 10.3.1 Global Deep Brain Stimulation Sales Growth (2014-2019)
- 10.3.2 Global Deep Brain Stimulation Price (2014-2019)
- 10.4 Sacral Nerve Stimulation Sales Growth and Price
- 10.4.1 Global Sacral Nerve Stimulation Sales Growth (2014-2019)
- 10.4.2 Global Sacral Nerve Stimulation Price (2014-2019)
- 10.5 Vagal Nerve Stimulation Sales Growth and Price
- 10.5.1 Global Vagal Nerve Stimulation Sales Growth (2014-2019)
- 10.5.2 Global Vagal Nerve Stimulation Price (2014-2019)
- 10.6 Gastric Stimulation Sales Growth and Price
- 10.6.1 Global Gastric Stimulation Sales Growth (2014-2019)
- 10.6.2 Global Gastric Stimulation Price (2014-2019)
- 10.7 Transcranial magnetic Stimulation Sales Growth and Price
- 10.7.1 Global Transcranial magnetic Stimulation Sales Growth (2014-2019)
- 10.7.2 Global Transcranial magnetic Stimulation Price (2014-2019)
- 10.8 Transcutaneous Electrical Stimulation Sales Growth and Price
- 10.8.1 Global Transcutaneous Electrical Stimulation Sales Growth (2014-2019)
- 10.8.2 Global Transcutaneous Electrical Stimulation Price (2014-2019)
- 10.9 Other Sales Growth and Price
- 10.9.1 Global Other Sales Growth (2014-2019)
- 10.9.2 Global Other Price (2014-2019)
11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment by Application
- 11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2014-2019)
- 11.2 Parkinson's disease Sales Growth (2014-2019)
- 11.3 Epilepsy Sales Growth (2014-2019)
- 11.4 Pain Sales Growth (2014-2019)
- 11.5 Other Sales Growth (2014-2019)
12 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2019-2024)
- 12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Regions (2019-2024)
- 12.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2019-2024)
- 12.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2019-2024)
- 12.2.4 South America Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2019-2024)
- 12.3 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Type (2019-2024)
- 12.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2019-2024)
- 12.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Type (2019-2024)
- 12.4 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Application (2019-2024)
- 12.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2019-2024)
- 12.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Neuromodulation Devices and Implantable Infusion Pumps . Industry analysis & Market Report on Neuromodulation Devices and Implantable Infusion Pumps is a syndicated market report, published as Global Neuromodulation Devices and Implantable Infusion Pumps Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Neuromodulation Devices and Implantable Infusion Pumps market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
